Vericel Stock: 6 Straight Green Days, Up 45%
Shares of Vericel (VCEL) have closed higher in each of the last 6 sessions, a cumulative gain of 45.0%. That added about $928 million to the company’s market value, which now stands at about $3.0 billion. The stock closed at $58.39 on Monday, November 9, its highest close of the past year.
VCEL Versus The S&P 500
Returns for VCEL and the S&P 500 over the streak and the periods around it, all ending Monday, November 9 and including dividends:
| Return Period | VCEL | S&P 500 |
|---|---|---|
| 1 Day | 6.9% | 2.3% |
| 6 Days (Current Streak) | 45.0% | -0.4% |
| 1 Month (21 Trading Days) | 45.6% | -3.3% |
| 3 Months (63 Trading Days) | 31.7% | -2.1% |
| Year To Date | 62.1% | 11.3% |
| 1 Year (252 Trading Days) | 50.7% | 13.7% |
How The Streak Compares With The Market
Over the same 6 trading days, the S&P 500 returned -0.4% including dividends, so the run is mostly Vericel’s own story rather than the market’s. Over the past three months the stock is up 31.7%, a window that includes the streak; over the other 57 sessions of that window it was down 9.2%.
What The Numbers Say About The Rally
On the fundamentals, revenue grew 25.3% over the last twelve months, against a median of 7.9% for S&P 500 Health Care stocks; and its operating margin is 8.3%, versus a median of 17.4%. At least one of the last four quarters was a loss, so a price-to-earnings multiple would not be a meaningful yardstick here. The read is mixed: revenue growth above the median on one side, margins below the median on the other.
A climb like this is worth respecting, and worth testing. Our Guidance Momentum screen tracks the stocks whose companies just raised their own forward numbers.
Streaks End. Discipline Compounds
A run like this is genuinely useful information: something about this business has the market’s full attention. But streaks are where discipline gets tested, because the urge to chase strength is strongest right before it pauses.
The Trefis High Quality (HQ) Portfolio channels that urge into a system: roughly 30 businesses selected for consistent cash generation, strong margins, and resilient balance sheets, sized and rebalanced with rules rather than excitement. It has a track record of outpacing a benchmark that combines the S&P 500, the S&P MidCap 400, and the Russell 2000. Enjoy the streak; own the process.